JF
TBPH icon

Jump Financial’s Theravance Biopharma TBPH Stock Holding History

Jump Financial’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,987
Closed -$786K – 2387
2025
Q4 		$786K Buy
41,987
+1,187
+3% +$19.7K 0.01% 1084
2025
Q3 		$596K Sell
40,800
-38,274
-48% -$484K 0.01% 1226
2025
Q2 		$872K Buy
+79,074
New +$769K 0.01% 1026
2024
Q2 		– Sell
-43,447
Closed -$390K – 2250
2024
Q1 		$390K Buy
+43,447
New +$403K 0.01% 1312
2023
Q3 		– Sell
-10,434
Closed -$108K – 2247
2023
Q2 		$108K Buy
+10,434
New +$115K ﹤0.01% 1642
2023
Q1 		– Sell
-49,800
Closed -$559K – 2053
2022
Q4 		$559K Sell
49,800
-8,200
-14% -$86.2K 0.03% 722
2022
Q3 		$588K Buy
+58,000
New +$543K 0.02% 827
2022
Q1 		– Sell
-11,900
Closed -$131K – 1904
2021
Q4 		$131K Buy
+11,900
New +$104K 0.01% 1190

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's TBPH Position: Q1 2026 in Review

Jump Financial sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 41,987 shares — an estimated $786K sold.

Jump Financial first reported a position in TBPH in Q4 2021 and held it in 8 quarters. The position peaked at $872K in Q2 2025. 174 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Jump Financial reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 41,987 Theravance Biopharma shares in Q1 2026, an estimated $786K.
  • Jump Financial first reported a position in Theravance Biopharma in Q4 2021 and held it in 8 quarters.
  • Jump Financial's Theravance Biopharma position peaked at $872K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.